Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Zhongguo Zhen Jiu ; 41(2): 213-6, 2021 Feb 12.
Article in Chinese | MEDLINE | ID: mdl-33788473

ABSTRACT

The teaching effect of "process management and evaluation" was assessed in resident standardization training plan in acupuncture-moxibustion department of hospital for postgraduates of non-acupuncture-moxibustion speciality. A total of 120 postgraduates of non-acupuncture-moxibustion speciality participating in resident standardization training were randomized into an observation group (60 cases) and a control group (60 cases, 1 case dropped off). In the control group, the conventional training mode was used. In the observation group, the "process management and evaluation" was adopted, in which, the syllabus was refined, various teaching modes were cooperated and the summary was conducted once a week. The training results were evaluated at the end of 1-month shift test and questionnaire was issued in all of the postgraduates of the two groups. In the observation group, the score for theory and the score of each of the items for technical ability, named differentiation and treatment, technical manipulation and physician-patient communication, as well as the total score were all higher than the control group successively (P<0.05, P<0.01). The results of the student questionnaire showed that in the items as "being liable to the memory of relevant knowledge" "connection of theory with practical ability" "stimulating students' interest and subjective initiative" "self-learning ability" "clinical question handling ability" and "communication ability with patients" as well as the total score in the observation group were all higher than the control group successively (P<0.01, P<0.05). The teaching effect of "process management and evaluation" is obviously better than the conventional teaching mode.


Subject(s)
Acupuncture Therapy , Acupuncture , Moxibustion , Hospitals , Humans , Reference Standards
2.
J Pharmacol Sci ; 122(4): 305-17, 2013.
Article in English | MEDLINE | ID: mdl-23966052

ABSTRACT

An accumulating body of evidence suggests that Alzheimer's disease (AD) is associated with microglia-mediated neuroinflammation and pro-inflammatory cytokine expression. Therefore, the suppression of neuroinflammation and pro-inflammatory cytokine might theoretically slow down the progression of AD. Xanthoceraside, a novel triterpenoid saponin extracted from the husks of Xanthoceras sorbifolia Bunge, has potent antiinflammatory and neuroprotective effects. However, the molecular mechanism underlying its anti-inflammatory action remains unclear. In the present study, we attempted to determine the effects of xanthoceraside on the production of pro-inflammatory mediators in amyloid ß25-35 (Aß25-35)/interferon-γ (IFN-γ)-stimulated microglia. Our results indicated that xanthoceraside (0.01 and 0.1 µM) significantly inhibited the release of nitric oxide (NO) and pro-inflammatory cytokines interleukin-1ß and tumor necrosis factor-α in a concentration-dependent manner. Reverse transcriptase-polymerase chain reaction and western blotting analyses showed that xanthoceraside decreased the Aß25-35/IFN-γ-induced production of cyclooxygenase-2 and inducible NO synthase. These effects were accompanied by inhibited activities of nuclear factor-κB and mitogen-activated protein kinase through Toll-like receptor 2 in a myeloid differentiation protein 88-dependent manner. Our results provide support for the therapeutic potential of xanthoceraside in AD.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/pharmacology , Anti-Inflammatory Agents , Interferon-gamma/pharmacology , Interleukin-1beta/metabolism , Mitogen-Activated Protein Kinases/physiology , Myeloid Differentiation Factor 88/physiology , NF-kappa B/physiology , Neuroprotective Agents , Peptide Fragments/pharmacology , Saponins/pharmacology , Signal Transduction/genetics , Signal Transduction/physiology , Toll-Like Receptor 2/physiology , Triterpenes/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Alzheimer Disease/genetics , Animals , Cells, Cultured , Depression, Chemical , Dose-Response Relationship, Drug , Mice , Microglia , Molecular Targeted Therapy , NF-kappa B/metabolism , Saponins/therapeutic use , Triterpenes/therapeutic use
3.
Bing Du Xue Bao ; 28(1): 7-14, 2012 Jan.
Article in Chinese | MEDLINE | ID: mdl-22416344

ABSTRACT

Samples of chicken, duck, quail, and pigeon were collected from Jiangsu, Anhui, and Hebei in 2009-2011, and sixteen H9N2 subtype isolates of avian influenza virus (AIV) were identified. The eight full-length genes of 16 AIV isolates were amplified by RT-PCR and sequenced. Genome sequence analysis showed that the amino acid motif of cleavage sites in the HA gene was P-S-R/K-S-S-R, which was consistent with the characterization of the LPAIV, and the Leucine (L) at the amino acid position 226 in the HA genes of all isolates indicated the potential of binding with SAalpha, 2-6 receptor. All isolates had a S to N substitution at residue 31 in the M2 gene, which is related to the resistance phenotype of adamantanes. The key molecular features of 16 AIV isolates from different hosts were same. Genome phylogenetic analysis revealed that all 16 H9N2 subtype AIVs originated from F98-like virus as backbone and formed two new genotypes through reassortment with HA gene of Y280-like virus and PB2 and M genes of G1-like virus. Our findings suggest that more attention should be paid to the surveillance of H9N2 influenza virus and its direction of reassortment.


Subject(s)
Genome, Viral , Influenza A Virus, H9N2 Subtype/genetics , Phylogeny , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Influenza A Virus, H9N2 Subtype/classification , Neuraminidase/genetics , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...